Sotera Health Co (OQ:SHC)

Sector:  Healthcare Industry:  Healthcare Facilities & Services
See Regulatory Filings on SEC
Company Contact
Address: 9100 South Hills Blvd
Suite 300, Suite 300
Tel: N/A
IR: See website
Key People
Business Overview
Sotera Health Company., is a medical device company. The Company is a provider of sterilization and lab testing and advisory services to the medical device and pharmaceutical industries. The Company has three segments: Sterigenics, Nordion and Nelson Labs. It focuses on sterilization services and lab services. The Sterilization Services includes products, such as medical protective barriers, including personal protective equipment, procedure kits and trays, catheters, wound care products, laboratory products and pharmaceuticals. The lab services offer microbiology testing services, analytical chemistry lab testing and advisory services. Medical device lab testing services include microbiology, biocompatibility and toxicology assessments, sterility assurance, packaging validation and distribution simulation, and reprocessing validations. The pharmaceutical lab testing services include microbiology, biocompatibility and toxicology assessments, extractables and sterilization validation.
Financial Overview
For the nine months ended 30 September 2020, SoteraHealth Co revenues increased 3% to $601.3M. Net incomedecreased 28% to $5.1M. Revenues reflect an increase indemand for the Company's products and services due tofavorable market conditions. Net income was offset byInterest expense, net increase of 46% to $167.1M (expense),Selling, general and administrati increase of 22% to $81.4M(expense).
Employees: 2,900 as of Sep 30, 2020
Reporting Currency: U.S. Dollars
Enterprise value: $10,341M as of Sep 30, 2020
Annual revenue (TTM): $794.80M as of Sep 30, 2020
EBITDA (TTM): $380.25M as of Sep 30, 2020
Net annual income (TTM): -$22.84M as of Sep 30, 2020
Free cash flow (TTM): $54.55M as of Sep 30, 2020
Net Debt Last Fiscal Year: $2,833M as of Sep 30, 2020
Shares outstanding: 277,431,755 as of Nov 20, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.